Current Pharmacogenomics and Personalized Medicine
Title:Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?
Volume: 10 Issue: 3
Author(s): Christopher Reist, Jogeshwar Mukherjee and Joseph C. Wu
Affiliation:
Keywords: Antipsychotic, Blood-brain-barrier, Dopamine receptor, Neuroimaging, P-glycoprotein, Pituitary.
Export Options
About this article
Cite this article as:
Reist Christopher, Mukherjee Jogeshwar and C. Wu Joseph, Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?, Current Pharmacogenomics and Personalized Medicine 2012; 10 (3) . https://dx.doi.org/10.2174/187569212802509979
DOI https://dx.doi.org/10.2174/187569212802509979 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times
Current Neuropharmacology Adolescent Peer Victimization and PTSD Risk
Adolescent Psychiatry Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders)
Current Neuropharmacology Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?
Current Medicinal Chemistry - Central Nervous System Agents Biomarkers of Oxidative Stress in the Assessment of Enantioselective Toxicity of Chiral Pesticides
Current Protein & Peptide Science The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap
Current Pharmaceutical Design Guanine-Quadruplexes Studied by Fluorescence Techniques
Current Analytical Chemistry Synaptic Elimination in Neurological Disorders
Current Neuropharmacology Targeting Leukotrienes for the Treatment of COPD?
Inflammation & Allergy - Drug Targets (Discontinued) Citrullinated Peptides in the Diagnosis of Rheumatoid Arthritis
Current Topics in Medicinal Chemistry Self-Assembled Nanoparticles of Natural Phytochemicals (Berberine and 3,4,5-Methoxycinnamic Acid) Originated from Traditional Chinese Medicine for Inhibiting Multidrug-Resistant <i>Staphylococcus aureus</i>
Current Drug Delivery Protease Inhibitors with Antileishmanial Activity
Current Enzyme Inhibition Expression and Purification of Uniformly 15N-Labeled Amyloid β Peptide 1-40 in Escherichia coli
Protein & Peptide Letters Neuroprotective Effects of Non-Classical Estrogen-Like Signaling Activators: from Mechanism to Potential Implications
CNS & Neurological Disorders - Drug Targets Consequences of Cannabinoid and Monoaminergic System Disruption in a Mouse Model of Autism Spectrum Disorders
Current Neuropharmacology The Leptin System: A Potential Target for Sepsis Induced Immune Suppression
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections :
Recent Patents on Cardiovascular Drug Discovery The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses
Endocrine, Metabolic & Immune Disorders - Drug Targets Pathophysiology and Prevention of Bronchopulmonary Dysplasia
Current Pediatric Reviews